High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: Toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome

G. Somlo, J. H. Doroshow, T. Synold, J. Longmate, D. Reardon, W. Chow, S. J. Forman, L. A. Leong, K. A. Margolin, Jr J. Morgan, J. W. Raschko, S. I. Shibata, M. L. Tetef, Y. Yen, N. Kogut, J. Schriber, J. Alvarnas

Research output: Contribution to journalArticle

27 Citations (Scopus)

Fingerprint Dive into the research topics of 'High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: Toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome'. Together they form a unique fingerprint.

Medicine & Life Sciences